325 related articles for article (PubMed ID: 12674333)
1. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study.
Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L
J Bone Miner Res; 2003 Apr; 18(4):723-9. PubMed ID: 12674333
[TBL] [Abstract][Full Text] [Related]
2. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study.
Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L
Bone; 2005 Mar; 36(3):577-83. PubMed ID: 15777680
[TBL] [Abstract][Full Text] [Related]
3. Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele.
Yazdanpanah N; Uitterlinden AG; Zillikens MC; Jhamai M; Rivadeneira F; Hofman A; de Jonge R; Lindemans J; Pols HA; van Meurs JB
J Bone Miner Res; 2008 Jan; 23(1):86-94. PubMed ID: 17725378
[TBL] [Abstract][Full Text] [Related]
4. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study.
Golbahar J; Hamidi A; Aminzadeh MA; Omrani GR
Bone; 2004 Sep; 35(3):760-5. PubMed ID: 15336613
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
[TBL] [Abstract][Full Text] [Related]
6. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study.
Abrahamsen B; Jørgensen HL; Nielsen TL; Andersen M; Haug E; Schwarz P; Hagen C; Brixen K
Bone; 2006 Feb; 38(2):215-9. PubMed ID: 16169307
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density.
Macdonald HM; McGuigan FE; Fraser WD; New SA; Ralston SH; Reid DM
Bone; 2004 Oct; 35(4):957-64. PubMed ID: 15454103
[TBL] [Abstract][Full Text] [Related]
8. Analysis of three functional polymorphisms in relation to osteoporosis phenotypes: replication in a Spanish cohort.
Agueda L; Urreizti R; Bustamante M; Jurado S; Garcia-Giralt N; Díez-Pérez A; Nogués X; Mellibovsky L; Grinberg D; Balcells S
Calcif Tissue Int; 2010 Jul; 87(1):14-24. PubMed ID: 20390408
[TBL] [Abstract][Full Text] [Related]
9. No association between hip geometry and four common polymorphisms associated with fracture: the Danish osteoporosis prevention study.
Nissen N; Madsen JS; Bladbjerg EM; Beck Jensen JE; Jørgensen NR; Langdahl B; Abrahamsen B; Brixen K
Calcif Tissue Int; 2009 Apr; 84(4):276-85. PubMed ID: 19225709
[TBL] [Abstract][Full Text] [Related]
10. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study.
Schoofs MW; van der Klift M; Hofman A; van Duijn CM; Stricker BH; Pols HA; Uitterlinden AG
J Bone Miner Res; 2004 Sep; 19(9):1490-6. PubMed ID: 15312249
[TBL] [Abstract][Full Text] [Related]
11. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
MacDonald HM; McGuigan FA; New SA; Campbell MK; Golden MH; Ralston SH; Reid DM
J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
[TBL] [Abstract][Full Text] [Related]
13. MTHFR polymorphism and bone mineral density: meta-analysis of published studies.
Riancho JA; Valero C; Zarrabeitia MT
Calcif Tissue Int; 2006 Nov; 79(5):289-93. PubMed ID: 17115239
[TBL] [Abstract][Full Text] [Related]
14. Two polymorphisms in the vitamin D receptor gene--association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study.
Tofteng CL; Jensen JE; Abrahamsen B; Odum L; Brot C
J Bone Miner Res; 2002 Aug; 17(8):1535-44. PubMed ID: 12162507
[TBL] [Abstract][Full Text] [Related]
15. [Association of bone mineral density with vitamin D receptor gene polymorphism--changes in radial bone mineral density with long-term follow-up: longitudinal study].
Murakami F; Hagino H; Shimomura T; Ikawa S; Hirano Y; Iijima K; Yamamoto K
Rinsho Byori; 1998 Aug; 46(8):766-73. PubMed ID: 9760828
[TBL] [Abstract][Full Text] [Related]
16. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
[TBL] [Abstract][Full Text] [Related]
17. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Matsuzaki T; Yoneshima H; Marumo F;
Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
[TBL] [Abstract][Full Text] [Related]
18. The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study.
Rivadeneira F; Houwing-Duistermaat JJ; Beck TJ; Janssen JA; Hofman A; Pols HA; Van Duijn CM; Uitterlinden AG
J Bone Miner Res; 2004 Aug; 19(8):1280-90. PubMed ID: 15231015
[TBL] [Abstract][Full Text] [Related]
19. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women.
McClure L; Eccleshall TR; Gross C; Villa ML; Lin N; Ramaswamy V; Kohlmeier L; Kelsey JL; Marcus R; Feldman D
J Bone Miner Res; 1997 Feb; 12(2):234-40. PubMed ID: 9041055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
